0001209191-23-042937.txt : 20230720
0001209191-23-042937.hdr.sgml : 20230720
20230720174753
ACCESSION NUMBER: 0001209191-23-042937
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230720
DATE AS OF CHANGE: 20230720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Durgam Suresh K.
CENTRAL INDEX KEY: 0001829958
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 231100652
MAIL ADDRESS:
STREET 1: C/O INTER-CELLULAR THERAPIES, INC.
STREET 2: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-07-17
0
0001567514
Intra-Cellular Therapies, Inc.
ITCI
0001829958
Durgam Suresh K.
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET
NEW YORK
NY
10016
0
1
0
0
EVP, Chief Medical Officer
1
Common Stock
2023-07-17
4
S
0
1842
65.00
D
21262
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2023.
s/ Lawrence J. Hineline, Attorney-in-fact
2023-07-20